Loading clinical trials...
Loading clinical trials...
A Multimodal Deep Learning-Driven Study for Perioperative Risk Stratification and Precision Intervention in Hepatocellular Carcinoma Recurrence
Conditions
Interventions
Neoadjuvant HAIC + Lenvatinib + PD-1 Inhibitor
Curative Liver Resection
+1 more
Locations
1
China
Tongji Hospital
Wuhan, Hubei, China
Start Date
October 26, 2025
Primary Completion Date
June 30, 2027
Completion Date
June 30, 2028
Last Updated
December 18, 2025
Lead Sponsor
Tongji Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions